Valion Bio

TIVC
CUSIP 888705209 Nasdaq COMMON STOCK
Reported in filings as: TIVIC HEALTH SYSTEMS INC

Institutional ownership · Q4 2024

Institutional holders 9 -1 (-10.0%) vs Q3 2024
Reported value $90.7K +30.0% vs Q3 2024
Shares held 267.9K -12.2K shares
Quarter Q4 2024 Period ended Dec 31, 2024

9 institutional managers reported holding 267,877 shares worth $90,654 on Form 13F for Q4 2024, against 10 in Q3 2024. Share positions on CUSIP 888705209 only; option legs and principal-amount lines are not counted.

Top 9 institutional holders · Q4 2024

Largest Q4 2024 Form 13F holders of CUSIP 888705209 by reported value
# Manager Shares Value % of portfolio Change Position page
1 HRT FINANCIAL LP 58,658 $19.0K < 0.01% New Position
2 UBS Group AG 54,808 $19.0K < 0.01% -39.5K Position
3 VANGUARD GROUP INC 47,981 $16.3K < 0.01% — Position
4 Ground Swell Capital LLC 38,568 $13.1K 0.02% New Position
5 GEODE CAPITAL MANAGEMENT LLC 36,457 $12.4K < 0.01% — Position
6 Tower Research Capital LLC TRC 18,884 $6.5K < 0.01% +526 Position
7 TWO SIGMA INVESTMENTS LP 12,147 $4.2K < 0.01% New Position
8 SBI Securities Co Ltd 306 $106 < 0.01% — Position
9 Bank of America Corporation 68 $24 < 0.01% +17 Position

Values as reported on each manager's Q4 2024 Form 13F. Change is in shares against the manager's prior-quarter filing.

13F holders by quarter

Form 13F holders of CUSIP 888705209 by quarter
Quarter Holders Shares Value
Q4 2024 9 -1 267.9K $90.7K
Q3 2024 10 280.1K $69.8K
Q2 2024 10 +5 618.3K $240.6K
Q1 2024 5 -2 67.3K $83.8K
Q4 2023 7 +1 62.0K $112.0K
Q3 2023 6 18.3K $31.7K

Q3 2023–Q4 2024, as reported on Form 13F.

Insiders · Form 4

Net insider transactions, 12 months +$28.4K 2 filings with purchases ($28.4K), 0 filings with sales ($0)
Latest filings
All Valion Bio insider filings

Annual & quarterly reports

  • 10-K · FY2025 Filed 2026-03-30
    Business · Risk Factors · Management's Discussion and Analysis
All Valion Bio SEC filings

Federal lobbying

Spend, trailing 12 months $20.0K Through Q3 2026, from quarterly LD-2 reports
Valion Bio lobbying profile

Ownership explorer

Loading ownership explorer…

Security Details

CUSIP 888705209
FIGI BBG00PT2YC13
Symbol TIVC
Type Common stock
Class COM NEW as filed on 13F
Exchange Nasdaq
Company Valion Bio

Other securities from this issuer

Name Symbol CUSIP Type
TIVIC HEALTH SYSTEMS INC VBIO 888705308 Common stock

Identifier History

Type Value From To
SYMBOL VBIO 2026-04-28 Current
FIGI BBG00PT2YC13 2026-02-07 Current
CUSIP 888705308 2025-03-10 2025-03-10
CUSIP 888705209 2023-08-25 2025-09-30
CUSIP 888705209 2023-08-23 Current
SYMBOL TIVC 2021-11-15 2026-04-27
CUSIP 888705100 2021-11-15 2023-09-30

Listing History

Symbol Exchange From To
VBIO Nasdaq 2026-05-06 Current
TIVC Nasdaq 2025-03-10 Current
TIVC Nasdaq 2023-08-25 Current
TIVC Nasdaq 2021-11-15 Current